Costs of paediatric diabetes care in Germany: current situation and comparison with the year 2000

Diabet. Med. 29, 1327–1334 (2012)

[1]  D. Lairson,et al.  Predictors of direct costs of diabetes care in pediatric patients with type 1 diabetes , 2011, Pediatric diabetes.

[2]  J. Rosenbauer,et al.  Frequency of SMBG correlates with HbA1c and acute complications in children and adolescents with type 1 diabetes , 2011, Pediatric diabetes.

[3]  H. Hauner,et al.  Direct costs of diabetes mellitus in Germany - CoDiM 2000-2007. , 2011, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[4]  Anthony O'Hagan,et al.  Review of Statistical Methods for Analysing Healthcare Resources and Costs , 2010, Health economics.

[5]  A. Hattersley,et al.  Entities and frequency of neonatal diabetes: data from the diabetes documentation and quality management system (DPV) , 2010, Diabetic medicine : a journal of the British Diabetic Association.

[6]  J. Rosenbauer,et al.  Häufigkeit des Diabetes mellitus im Kindes- und Jugendalter in Deutschland , 2010, Der Diabetologe.

[7]  C. Clar,et al.  Self-monitoring of blood glucose in type 2 diabetes: systematic review. , 2010, Health technology assessment.

[8]  E. Cummins,et al.  Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation. , 2010, Health technology assessment.

[9]  A. Green,et al.  Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration study , 2009, The Lancet.

[10]  J. Rosenbauer,et al.  Changes in the Use of Analogue Insulins in 37 206 Children and Adolescents with Type 1 Diabetes in 275 German and Austrian Centers during the Last Twelve Years , 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[11]  J. Carstensen,et al.  Age‐specific direct healthcare costs attributable to diabetes in a Swedish population: a register‐based analysis , 2008, Diabetic medicine : a journal of the British Diabetic Association.

[12]  J. Kreuder,et al.  Arterial Hypertension Determined by Ambulatory Blood Pressure Profiles , 2008, Diabetes Care.

[13]  J. Rosenbauer,et al.  Metabolic control as reflectet by HbA1c in children, adolescents and young adults with type-1 diabetes mellitus: combined longitudinal analysis including 27,035 patients from 207 centers in Germany and Austria during the last decade , 2008, European Journal of Pediatrics.

[14]  J. Bottomley,et al.  Economic costs of diabetes in the US in 2007 — Implications for Europe , 2008 .

[15]  M. Rewers,et al.  Assessment and monitoring of glycemic control in children and adolescents with diabetes , 2007, Pediatric diabetes.

[16]  Ping Zhang,et al.  The relationship between age and healthcare expenditure among persons with diabetes mellitus , 2007, Expert opinion on pharmacotherapy.

[17]  W. Tamborlane,et al.  Optimal control of type 1 diabetes mellitus in youth receiving intensive treatment. , 2006, The Journal of pediatrics.

[18]  G. Chodick,et al.  The direct medical cost of diabetes in Israel , 2005, The European Journal of Health Economics.

[19]  W. Rathmann,et al.  Direct costs of pediatric diabetes care in Germany and their predictors. , 2004, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[20]  Xiaonan Xue,et al.  Estimating the relative risk in cohort studies and clinical trials of common outcomes. , 2003, American journal of epidemiology.

[21]  P. Hogan,et al.  Economic Costs of Diabetes in the U.S. in 2002 , 2003, Diabetes care.

[22]  W. Rathmann,et al.  Hospitalization among diabetic children and adolescents and the general population in Germany. German Working Group for Pediatric Diabetology. , 2001, Diabetes care.

[23]  P. M. Jonsson,et al.  Excess costs of medical care 1 and 8 years after diagnosis of diabetes: estimates from young and middle-aged incidence cohorts in Sweden. , 2000, Diabetes research and clinical practice.

[24]  S. Thompson,et al.  How should cost data in pragmatic randomised trials be analysed? , 2000, BMJ : British Medical Journal.

[25]  S. Marshall,et al.  Standardization of HbA1c measurements − a consensus statement , 2000, Annals of clinical biochemistry.

[26]  E. Kilpatrick,et al.  Glycated haemoglobin values: problems in assessing blood glucose control in diabetes mellitus , 1994, BMJ.

[27]  C. Morris,et al.  A Comparison of Alternative Models for the Demand for Medical Care , 1983 .

[28]  R. Calzada-León,et al.  Economic Family Burden of Metabolic Control in Children and Adolescents with Type I Diabetes Mellitus , 2008, Journal of pediatric endocrinology & metabolism : JPEM.

[29]  J. Rosenbauer,et al.  Metabolic control as reflected by HbA1c in children, adolescents and young adults with type-1 diabetes mellitus: combined longitudinal analysis including 27,035 patients from 207 centers in Germany and Austria during the last decade. , 2008, European journal of pediatrics.

[30]  J. Leahy.  Economic Costs of Diabetes in the U.S. in 2007 , 2008 .

[31]  M. Hadavi.  Diabetes Management , 2006 .

[32]  W. Rathmann,et al.  Direct Costs of Care in Germany for Children and Adolescents with Diabetes Mellitus in the Early Course After Onset , 2004, Journal of pediatric endocrinology & metabolism : JPEM.

[33]  G. Giani,et al.  Social inequality in childhood diabetes--a population-based follow-up study in Germany. , 2003, Pediatrics.